Development of a PCR-based test for the detection of Aspergillus species in broncheolar lavage samples
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2019 - 2021
Project Lead
Dr. Jayanthi
Authors
Dr. Jayanthi, Dr. Sweta, Dr. Pavana Thomas
Project Status
completed
Project Type
Co-PI